Risperdal is an atypical antipsychotic that is approved to treat bipolar disorder and schizophrenia in adults and children (between the ages of 10 and 17), as well as irritability associated with autism in children between the ages of 5 and 16. The drug is also sometimes used off-label to treat ADHD and other conditions. Risperdal did not receive approval from the U.S. Food & Drug Administration (FDA) for any pediatric indications until 2006.
Hundreds of Risperdal lawsuits have been filed on behalf of patients who allegedly developed serious side effects, including gynecomastia (male breast growth), due to their use of the drug.
Risperdal male breast growth lawsuits claim that the drug has been associated with increased levels of the hormone prolactin, which is associated with breast development in girls and lactation in nursing mothers. They further allege that Johnson & Johnson and its Janssen Pharmaceuticals unit concealed knowledge of Risperdal male breast growth, and improperly marketed the antipsychotic for use in children before the FDA cleared the drug for such uses.
Another atypical antipsychotic called Invega is made with an paliperidone, which is an active metabolite of the active ingredient in Risperdal. Invega lawsuits that allege the drug caused gynecomastia are also being investigated by Bernstein Liebhard LLP at this time.
The connection between Risperdal and increased prolactin levels in children was reported in research that appeared in the Journal of Clinical Psychopharmacology in 2006.
Parents and caregivers of boys who are being treated with this powerful antipsychotic drug should be aware of the signs and symptoms of Risperdal gynecomastia, including:
Risperdal male breast growth is difficult to treat, as the excess tissue will remain even once a patient stops taking the medication. To eliminate the tissue, surgery is usually required. This can include liposuction, and even mastectomy to remove the breasts in the most serious cases of Risperdal gynecomastia.
Johnson & Johnson reportedly settled five Risperdal gynecomastia lawsuits in 2012 for undisclosed amounts. The cases had been filed in a consolidated litigation in Pennsylvania’s Philadelphia Court of Common Pleas, and were being prepared for trial.
Yes. The settlement was announced in November 2013, and resolved allegations that Johnson & Johnson and its Janssen unit had improperly marketed Risperdal and other drugs. Among other things, the companies agreed to pay more than $2 billion to resolve criminal and civil charges brought by the U.S. Justice Department. Among other things, the government had accused Johnson & Johnson and Janssen of concealing Risperdal side effects, including gynecomastia, and marketing the drug for off-label uses.
If you would like to obtain compensation for damages incurred due to Risperdal gynecomastia, it is important to contact an attorney with experience pursuing drug injury product liability cases. The nationwide law firm of Bernstein Liebhard LLP is now evaluating Risperdal lawsuits involving male breast growth, and our legal staff can help you determine if you have a valid claim. We’ve fought on the side of injured consumers for over 20 years, and have recovered more than $3 billion for our clients.
At Bernstein Liebhard LLP, our Risperdal lawyers are offering free legal reviews to victims of gynecomastia. You may rest assured that you will be under no obligation to retain our law firm if you contact us for an evaluation.
Nothing. Our Firm is accepting Risperdal lawsuit clients on a contingency basis, which means we only receive payment if your case results in a financial recovery in your favor. If the case is not successful, you will owe Bernstein Liebhard LLP nothing. If we do obtain a settlement or judgment on your behalf, your fees will be taken out of a portion of the recovery. Our fee arrangement is fully detailed in the retainer agreement you will sign should you choose Bernstein Liebhard LLP to represent you.
In our experience, it takes about two years for a product liability lawsuit to come to trial. However, that can vary greatly based on a number of circumstances. Of course, some cases settle before they go before a jury. But any type of settlement negotiations are not likely to begin until your Risperdal male breast claim has been prepared for trial.
You don’t have to worry about upsetting the relationship you have with your doctor in order to pursue a Risperdal gynecomastia lawsuit. These claims name Johnson & Johnson and Janssen as the primary defendants. Bernstein Liebhard LLP is not pursing medical malpractice claims involving Risperdal, and will not be targeting any physicians.
Yes. Bernstein Liebhard LLP is a nationwide law firm that represents clients in all 50 states, and we are accepting Risperdal lawsuit clients from throughout the country.
You simply need to pick up the phone and call our office, or fill out our online form, to begin the process of filing a Risperdal gynecomastia lawsuit. Our Risperdal attorneys will fully explain the criteria for filing suit, and will help you determine if you have a valid claim. To contact our office directly, please call .